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BACKGROUND
The risk of antepartum stillbirth at term is higher among women 35 years of age or 
older than among younger women. Labor induction may reduce the risk of stillbirth, 
but it also may increase the risk of cesarean delivery, which already is common in 
this older age group.
METHODS
We conducted a randomized, controlled trial involving primigravid women who were 
35 years of age or older. Women were randomly assigned to labor induction between 
39 weeks 0 days and 39 weeks 6 days of gestation or to expectant management (i.e., 
waiting until the spontaneous onset of labor or until the development of a medical 
problem that mandated induction). The primary outcome was cesarean delivery. The 
trial was not designed or powered to assess the effects of labor induction on stillbirth.
RESULTS
A total of 619 women underwent randomization. In an intention-to-treat analysis, 
there were no significant between-group differences in the percentage of women who 
underwent a cesarean section (98 of 304 women in the induction group [32%] and 
103 of 314 women in the expectant-management group [33%]; relative risk, 0.99; 95% 
confidence interval [CI], 0.87 to 1.14) or in the percentage of women who had a 
vaginal delivery with the use of forceps or vacuum (115 of 304 women [38%] and 104 
of 314 women [33%], respectively; relative risk, 1.30; 95% CI, 0.96 to 1.77). There were 
no maternal or infant deaths and no significant between-group differences in the 
women’s experience of childbirth or in the frequency of adverse maternal or neonatal 
outcomes.
CONCLUSIONS
Among women of advanced maternal age, induction of labor at 39 weeks of gestation, 
as compared with expectant management, had no significant effect on the rate of 
cesarean section and no adverse short-term effects on maternal or neonatal out-
comes. (Funded by the Research for Patient Benefit Programme of the National Insti-
tute for Health Research; Current Controlled Trials number, ISRCTN11517275.)
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The average age of women at child-birth in industrialized nations has been increasing steadily for approximately 30 
years.1 Between 1996 and 2006, births to women 
35 years of age or older in the United Kingdom 
increased from 12% to 20% of all births.2 In 
2006, a total of 5.6% of live births in the United 
Kingdom were to nulliparous women 35 years of 
age or older.
The risks of perinatal death, hypertensive dis-
ease, gestational diabetes mellitus, placenta pre-
via, and placental abruption are higher among 
women 35 years of age or older than among 
younger women.1,3,4 Older mothers are also at 
increased risk for preterm labor and for bearing 
infants with macrosomia (>3999 g) or low birth 
weight (<2500 g). The women themselves typi-
cally think that their age puts their infant at in-
creased risk for a poor outcome.3 Unsurprisingly, 
rates of obstetrical intervention are higher among 
older women than among younger women.
The rate of cesarean section is 38% among 
nulliparous women in the United Kingdom who 
are 35 years of age or older and 50% among 
those who are 40 years of age or older.3 Among 
nulliparous women, the relationship between 
maternal age and delivery by means of emer-
gency cesarean section is linear.5
Induction at or before the due date in women 
35 years of age or older may be beneficial be-
cause the gestational age at delivery that is associ-
ated with the lowest cumulative risk of perinatal 
death is 38 weeks.6 In all maternal age groups, 
the risk of stillbirth is higher among nulliparous 
women than among multiparous women.7,8 In-
duction is currently available to all women in the 
United Kingdom at 41 to 42 weeks of gestation, 
when the risk of stillbirth is 2 to 3 per 1000 
deliveries9,10; among older women, this risk is 
2.6 stillbirths per 1000 deliveries from 37 weeks 
of gestation onward.7 However, induction carries 
risks (e.g., cord prolapse and uterine hyper-
stimulation) and has been associated with an 
increased risk of cesarean section. In addition, 
its benefits may be offset by longer-term adverse 
outcomes in children because of delivery at 
“early-term” gestation (37 to 39 weeks).11-14
Some obstetricians in the United Kingdom 
already induce labor at the due date (40 weeks of 
gestation); rates of induction are 39% among 
women 40 to 44 years of age and 58% among 
women 45 years of age or older. Among obstetri-
cians who do not induce labor in older pregnant 
women at the due date, one third are reluctant 
to offer induction because they are concerned 
about increasing the likelihood of cesarean de-
livery, even though they think that induction 
would improve perinatal outcomes.15 However, 
there is a growing body of evidence that induc-
tion of labor at term for reasons other than 
older maternal age does not increase rates of 
cesarean section and may even reduce them16 and 
that an effective intervention is therefore being 
underused.
Most trials of induction at or near term have 
involved women with established complications 
of pregnancy such as hypertension,17 prelabor 
rupture of membranes,18 fetal growth restric-
tion,19 diabetes,20 or fetal macrosomia.21 The few 
trials of induction that did not involve women 
with complications22-25 were relatively small (a 
total of 1377 women in four trials), date from 
the 1970s, and may not be applicable to modern 
obstetrical practice. Trials of induction of labor 
in women of advanced maternal age are lacking. 
The 35/39 trial was designed to test the hypoth-
esis that induction of labor at 39 weeks of gesta-
tion would reduce the rate of cesarean delivery 
among nulliparous women of advanced mater-
nal age.
Me thods
Study Design and Oversight
We performed a multicenter, randomized, con-
trolled trial comparing the rate of cesarean 
section between women assigned to induction 
of labor between 39 weeks 0 days and 39 weeks 
6 days of gestation and those assigned to expect-
ant management. Eligible women were nullipa-
rous, were to be 35 years of age or older on their 
expected due date, and had a singleton live fetus 
in a cephalic presentation. Participants were re-
cruited between August 2012 and March 2015 at 
38 National Health Service (NHS) hospitals and 
1 Primary Care Trust organization in the United 
Kingdom.
Women were ineligible to participate in the 
trial if their pregnancy was complicated by a 
known fetal congenital abnormality that would 
lead to neonatal death or if they had any contra-
indications to labor (e.g., evidence of fetal com-
promise), vaginal delivery (e.g., placenta previa), 
or expectant management (e.g., gestational diabe-
A Quick Take 
is available at 
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tes). Women who had undergone a myomectomy, 
who had not undergone ultrasonographic exami-
nation (for estimation of gestational age) before 
22 weeks of gestation, or who had undergone 
in vitro fertilization with the use of donor eggs 
were also excluded.
The original trial protocol was published in 
2012.26 The original and final trial protocols are 
available with the full text of this article at 
NEJM.org. The first and last authors vouch for 
the accuracy and completeness of the data and 
for the fidelity of this report to the trial proto-
col. The Nottingham Clinical Trials Unit provided 
the trial database, computerized randomization 
program, and statistical support. The trial was 
approved by the East Midlands–Derby NHS re-
search ethics committee, and all participants 
provided written informed consent.
Participants
Women underwent randomization at 36 weeks 
0 days to 39 weeks 6 days of gestation. Individ-
ual women were assigned in a 1:1 ratio accord-
ing to a computer-generated code with the use 
of random permuted blocks of randomly varying 
size generated by the Nottingham Clinical Trials 
Unit. The randomization was stratified into three 
categories according to trial center and maternal 
age (35 to 37 years of age, 38 to 39 years of age, 
and 40 years of age or older).
After obtaining consent, research staff at in-
dividual sites logged into an Internet-based ran-
domization system to access the randomized 
assignments. Both participants and treating cli-
nicians were aware of these assignments.
Women were randomly assigned to either in-
duction of labor between 39 weeks 0 days and 
39 weeks 6 days of gestation or to expectant 
management (i.e., waiting for the spontaneous 
onset of labor unless a situation developed ne-
cessitating delivery either by means of induc-
tion or cesarean section). Women who were 
randomly assigned to the expectant-manage-
ment group could undergo induction between 
41 weeks 0 days and 42 weeks 0 days of gestation 
(i.e., 7 to 14 days after the due date), with the 
exact time determined by their preference and 
the physician’s usual practice. No additional 
monitoring before 42 weeks 0 days of gestation 
was offered unless it was the physician’s usual 
practice. If the woman declined to undergo 
induction at 42 weeks of gestation, she could 
undergo scanning to determine fetal growth 
and amniotic-f luid volume and daily or every-
other-day cardiotocographic monitoring accord-
ing to the physician’s usual practice. In the in-
duction group, local policies for induction of 
labor were followed.
Before the trial began, each unit recorded its 
regimen for the use of prostaglandin and oxyto-
cin and the Bishop cutoff score for amniotomy 
(scores range from 0 to 13, with higher scores 
indicating greater favorability for induction). 
Staff within each unit were encouraged to use 
the same induction protocol for all participants, 
including women in the expectant-management 
group who required induction for any reason.
Trial Outcomes
The primary outcome was cesarean delivery. The 
secondary maternal outcomes were the method 
of delivery other than cesarean section (i.e., un-
assisted vaginal delivery, assisted vaginal deliv-
ery [with the use of forceps or vacuum], and 
vaginal breech delivery), the onset of labor (i.e., 
spontaneous labor, induction of labor, elective or 
emergency cesarean, or no labor), the indication 
for induction of labor, the method of labor in-
duction, the indication for cesarean section, intra-
partum complications, and postpartum compli-
cations (e.g., systemic infection or the need for 
a blood transfusion). Postpartum hemorrhage 
was defined as a blood loss of 500 ml or more 
at vaginal delivery or 1000 ml or more at cesar-
ean delivery.
The secondary neonatal outcomes were live 
birth or stillbirth, birth weight, admission to a 
neonatal intensive care unit, birth trauma, and 
two composite outcomes for serious neonatal 
complications (direct trauma and hypoxia). The 
composite outcome for neonatal direct trauma 
included subdural hematoma, intracerebral or 
intraventricular hemorrhage, spinal cord injury, 
basal skull fracture, peripheral-nerve injury, and 
long-bone fracture. The composite outcome for 
neonatal hypoxia included seizures, hypotonia, 
abnormal level of consciousness, and the use of 
cooling. The components of the two neonatal 
composite outcomes (trauma and hypoxia) were 
prespecified in the statistical analysis plan be-
fore the trial randomization code was broken. 
Data were collected immediately after the moth-
ers’ hospital discharge by the research midwife 
at each center.
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Other secondary outcomes included the moth-
ers’ expectations and experience of childbirth, as 
measured with the use of the Childbirth Experi-
ence Questionnaire,27 which was sent to the 
women 1 month after the birth. This measure 
assesses four domains of the experience of 
childbirth: the woman’s own capacity (her sense 
of control and personal feelings during child-
birth), professional support (the woman’s receipt 
of information and midwifery care), perceived 
safety (the woman’s sense of security and mem-
ories from the childbirth), and participation in 
the birth (the woman’s ability to influence the 
birthing process). Responses were scored ac-
cording to the instructions of the authors of the 
questionnaire (Table S2 in the Supplementary 
Appendix, available at NEJM.org). Scores in each 
domain range from 0 to 4, with higher scores 
indicating a better childbirth experience. Data 
on additional secondary outcomes pertaining to 
resource use and the women’s baseline and post-
natal health status were also collected but are 
not reported here.
Statistical Analysis
The power calculation was based on rates of 
cesarean delivery among women who were preg-
nant with a singleton in cephalic presentation 
and who were in labor at term in the cohort of 
all delivering women in Scotland between 2004 
and 2008; 23% of the women in this cohort were 
35 to 39 years of age and 27% were 40 years of 
age or older (Smith G: unpublished data). We 
calculated that, assuming a rate of cesarean de-
livery of 25% among controls, a sample size of 
630 women would provide 80% power to test the 
hypothesis that induction of labor would reduce 
the rate of cesarean section to 16%, a 36% relative 
reduction (or a 9-percentage-point absolute re-
duction), at a two-sided significance level of 5%.
In this intention-to-treat analysis, participants 
were assessed according to their assigned group, 
regardless of their adherence to the assignment, 
and according to a prespecified statistical analy-
sis plan. For the primary outcome, a generalized 
linear model (with a binomial family and a log 
link) was used to calculate relative risk and 95% 
confidence intervals after adjustment for trial 
center and maternal age (the center was account-
ed for with the use of robust standard errors and 
a clustered sandwich estimator in Stata soft-
ware). We also had planned a sensitivity analysis 
to investigate the effect of missing data on our 
results, but this analysis was unnecessary because 
there were minimal missing data.
For analyses of the method of delivery (other 
than by cesarean section), we used a multino-
mial logistic-regression model to calculate rela-
tive risks and 95% confidence intervals after 
adjustment for trial center and maternal age, 
using vaginal delivery as the reference group. 
For intrapartum complications, postpartum com-
plications, and the composites of serious neona-
tal complications, we used the same generalized 
linear model that was used for the primary 
outcome to calculate relative risks and 95% con-
fidence intervals. For individual birth trauma 
outcomes, we summarized the frequency of these 
events in each group.
To assess the women’s experience of child-
birth as measured with the use of the Childbirth 
Experience Questionnaire,27 we performed a com-
plete case analysis, using the unpaired t-test, to 
compare the mean subscale scores and the mean 
total score (the average of the four individual 
subscale scores) between women in the induc-
tion group and those in the expectant-manage-
ment group. A Mann–Whitney U test was used 
to calculate P values. In cases in which there 
were a few missing items, the half-scale method 
was used so that when the respondent had an-
swered at least half the items in the scale, the 
sum of the scores was divided by the number of 
answered items.
For the primary outcome, a prespecified sub-
group analysis according to maternal age (35 to 
37 years, 38 to 39 years, or 40 years of age or 
older) was performed by including an interaction 
term in the model. An independent data and 
safety monitoring committee met regularly 
throughout the trial. No interim analyses were 
performed. All analyses were performed with 
the use of Stata software, version 13.
R esult s
Enrollment
Recruitment took place from August 2012 
through March 2015. Recruitment according to 
trial center is shown in Table S3 in the Supple-
mentary Appendix. One woman in the induction 
group withdrew consent for her data to be used. 
The numbers of participants who were random-
ly assigned to each group and who received the 
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intended strategy are shown in Figure 1. A total 
of 619 of 4542 women who were eligible to par-
ticipate in the trial (14%) underwent randomiza-
tion. Among the 46% of eligible nonparticipants 
who expressed a preference for one of the man-
agement strategies, 1595 of 1804 women (88%) 
preferred expectant management.
The baseline characteristics were similar in 
the two groups (Table 1). Nonadherence was 
more common in the induction group than in 
the expectant-management group (13% vs. 5%) 
(Table 2). There was no significant difference 
between the induction group and the expectant-
management group with respect to the frequency 
of cesarean section (98 of 304 women [32%] vs. 
103 of 314 women [33%]; relative risk, 0.99; 95% 
confidence interval [CI], 0.87 to 1.14). A total of 
115 of 304 women (38%) in the induction group, 
as compared with 104 of 314 women (33%) in 
the expectant-management group, had assisted 
vaginal delivery (relative risk, 1.30; 95% CI, 0.96 
to 1.77).
Outcomes
There were no significant between-group differ-
ences in maternal outcomes (Table 3) or neonatal 
outcomes (Table 4). Serious adverse events were 
Figure 1. Enrollment, Randomization, and Assessment.
619 Underwent randomization
6455 Women were evaluated
for eligibility
305 Were assigned to labor induction
265 Adhered to assigned strategy
314 Were assigned to expectant
management
297 Adhered to assigned strategy
304 Were included in analysis
1 Was excluded from analysis
(no outcome data available)
1 Withdrew consent
314 Were included in analysis
5836 Were excluded
1913 Did not meet the 
inclusion criteria
3923 Declined to participate
Variable
Induction 
Group 
(N = 305)
Expectant-
Management 
Group 
(N = 314)
Maternal age at expected date of delivery — yr
Mean ±SD 37±2.2 37±2.2
Range 35–45 35–44
Current smoker — no. (%) 9 (3) 5 (2)
Body-mass index ≥30 — no. (%)* 85 (28) 83 (26)
Race — no. (%)†
White 279 (91) 291 (93)
Other 26 (9) 21 (7)
Unknown 0 2 (1)
Assisted conception — no. (%) 40 (13) 48 (15)
Medical history — no. (%)
Any disease 48 (16) 50 (16)
Renal disease 0 1 (<1)
Hypertension 4 (1) 3 (1)
Other condition 46 (15) 46 (15)
*  Body-mass index is the weight in kilograms divided by the square of the height 
in meters.
†  Race was self-reported.
Table 1. Baseline Characteristics of the Participants.*
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reported in 10 women in the induction group 
(3%) and in 23 women in the expectant-manage-
ment group (7%); most of these events were in-
cluded in the prespecified secondary outcomes 
(Table S4 in the Supplementary Appendix). The 
groups did not differ materially with respect to 
the methods of induction (Table S5 in the Sup-
plementary Appendix). A subgroup analysis of 
the primary outcome according to maternal age 
showed no significant difference in the treatment 
effects according to age (P = 0.65 for the interac-
tion) (Table 3).
Variable
Induction 
 Group 
(N = 305)
Expectant-
Management 
 Group 
(N = 314)
Women who received assigned care — no. (%)* 264 (87) 297 (95)
Onset of birth process
Spontaneous labor — no. (%) 62 (20) 144 (46)
≤39 wk 6 days of gestation — no. 37
≥40 wk of gestation — no. 25
Induced labor — no. (%) 237 (78) 154 (49)
≤39 wk 6 days of gestation — no. 222
≥40 wk of gestation — no. 15
Elective cesarean section — no. (%) 3 (1) 9 (3)
≤39 wk 6 days of gestation — no. 2
≥40 wk of gestation — no. 1
Emergency cesarean section without labor — no. (%) 2 (1) 7 (2)
≤39 wk 6 days of gestation — no. 2
≥40 wk of gestation — no. 0
Indication for induction of labor — no.
Random assignment to induction 208 0
>41 wk of gestation 7 45
Preterm (<37 wk of gestation) prelabor rupture of membranes 1 1
Term (>37 wk of gestation) prelabor rupture of membranes 
>24 hr before induction
10 35
Fetal growth restriction 1 7
Reduced fetal movements 3 17
Pregnancy-induced hypertension 8 12
Preeclampsia 8 9
Obstetrical cholestasis 0 3
Gestational diabetes 1 2
Suspected fetal distress 0 5
Request of mother 0 17
Other indications 7 25
*  A total of 41 women in the induction group (13%) did not adhere to the assigned care strategy, including 25 women 
who labored spontaneously at 40 or more weeks of gestation, 15 who were induced at 40 or more weeks of gestation, 
and 1 who had an elective cesarean section after 40 weeks of gestation. Reasons for nonadherence included personal 
and family issues, hospital and logistic issues, research and clinical staffing issues, and various combinations of these 
factors. A total of 17 women in the expectant-management group (5%) did not adhere to the assigned care strategy be-
cause they requested induction or delivery by means of cesarean section before 41 completed weeks of gestation.
Table 2. Method of Delivery and Indication for Induction of Labor.
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In total, 512 women (83%) returned the 
Childbirth Experience Questionnaire. There were 
no significant differences between the two 
groups in the subgroup scores or total scores 
(indicating level of satisfaction with the child-
birth experience) (Table S6 in the Supplementary 
Appendix).
Discussion
In this multicenter, randomized trial involving 
women 35 years of age or older, induction of 
labor at 39 weeks of gestation, as compared with 
expectant management, had no significant effect 
on the rate of cesarean section. Moreover, mater-
Outcome
Induction 
 Group 
(N = 304)
Expectant-
Management 
Group 
(N = 314)
Relative Risk 
 (95% CI)† P Value
Method of delivery
Cesarean section — no. (%) 98 (32) 103 (33) 0.99 (0.87–1.14) 0.92
Age 35–37 yr‡ 44 (26) 52 (29) 0.89 (0.67–1.19) 0.45
Age 38–39 yr ‡ 29 (39) 27 (39) 1.00 (0.70–1.41) 0.99
Age ≥40 yr‡ 25 (42) 24 (38) 1.13 (0.75–1.70) 0.56
Assisted vaginal delivery — no. (%) 115 (38) 104 (33) 1.30 (0.96–1.77) 0.08
Indication for cesarean section — no.
Failure of labor to progress
First stage 39 34
Second stage 5 7
Failed delivery with use of instruments 4 7
Suspected fetal distress 43 48
Maternal complications 8 2
Patient choice 2 6
Other§ 32 29
Epidural use — no. (%) 105 (35) 90 (29)
Gestational age at onset of labor — wk
Mean 39 40
Range 37–42 36–42
Complications — no.
Placental abruption 0 0
Cord prolapse 1 0
Postpartum hemorrhage¶ 95 90 1.09 (0.85–1.40) 0.47
Shoulder dystocia 6 9 0.68 (0.25–1.83) 0.45
Blood transfusion required 10 17 0.61 (0.30–1.21) 0.16
Systemic infection‖ 12 10 1.24 (0.45–3.37) 0.68
*  CI denotes confidence interval.
†  Shown is the relative risk of the outcome in the induction group as compared with the expectant-management group, 
after adjustment for trial center and maternal age.
‡  P = 0.65 for the interaction, according to maternal age.
§  Other indications for cesarean section are provided in Table S7 in the Supplementary Appendix.
¶  Postpartum hemorrhage was defined as blood loss of 500 ml or more at vaginal delivery or 1000 ml or more at cesare-
an delivery.
‖  Systemic infection was defined by a temperature of 38°C or higher.
Table 3. Maternal Outcomes.*
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nal and neonatal outcomes and women’s experi-
ence of childbirth did not differ significantly 
between the groups assigned to these strategies.
Our trial had some limitations. It was re-
stricted to nulliparous women in the United 
Kingdom who did not have high-risk pregnan-
cies. Thus, the results may not be generalizable 
to older multiparous women and may not apply 
to all nulliparous pregnant women who are 35 
years of age or older. Although we found no 
significant between-group difference in the 
women’s experience of childbirth, this finding 
may not apply to women who have a preference 
for one strategy or the other.
The maximum time gap between random-
ization (36 weeks of gestation) and intervention 
(39 weeks of gestation) in our trial was imposed 
by the practical constraints of NHS maternity 
services. This limitation might not apply in 
other clinical settings. Because of this interval, 
Outcome
Induction 
 Group 
(N = 304)
Expectant-
Management 
Group 
(N = 314)
Relative Risk 
 (95% CI)† P Value
Liveborn infants — no. 304 314
Death — no.
Stillbirth (delivered with no signs of life after 24 wk 
of gestation) — no.
0 0
Before discharge from hospital 0 0
Female sex — no. (%) 152 (50) 167 (53)
Clinical measurements
Mean birth weight ±SD — g 3352±425 3428±466
Birth weight <2500 g — no. 4 6 0.68 (0.19–2.4) 0.56
Apgar score at 5 min — no.
<4 0 1
4–7 11 11 1.04 (0.40–2.69) 0.94
Umbilical-cord-blood arterial base deficit 
 >15 mmol/liter — no.
0 1
Umbilical-cord-blood arterial pH <7.00 — no. 1 1 0.89 (0.05–14.6) 0.93
Admission to NICU for >4 days — no. 6 7 0.88 (0.26–3.06) 0.85
Complication — no.
Composite outcome‡
Hypoxia 2 2 1.03 (0.14–7.50) 0.98
Hypotonia ≥2 hr 1 0
Required intervention — no.
Tube feeding >4 days 0 2
Intubation and ventilation >24 hr 1 2 0.51 (0.45–5.82) 0.59
Cooling 1 2 0.52 (0.47–5.68) 0.59
Oxygen 9 7 1.32 (0.58–2.99) 0.50
CPAP 4 4 1.02 (0.22–4.86) 0.97
*  CPAP denotes continuous positive airway pressure, and NICU neonatal intensive care unit.
†  Shown is the relative risk of the outcome in the induction group as compared with the expectant-management group, 
after adjustment for trial center and maternal age.
‡  The composite outcome for direct trauma includes subdural hematoma, intracerebral or intraventricular hemorrhage, 
spinal cord injury, basal skull fracture, peripheral-nerve injury, and long-bone fracture. The composite outcome for hy-
poxia includes seizures, hypotonia, abnormal level of consciousness, and the use of cooling. No cases of direct trauma, 
seizures, or abnormal level of consciousness were reported.
Table 4. Neonatal Outcomes.*
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some women in the intervention group entered 
labor spontaneously before their date for induc-
tion. Such “nonadherence” reduced the power of 
the trial but would not have biased the test for a 
difference between the groups because we used 
an intention-to-treat analysis.
This trial was powered to detect a 36% rela-
tive difference (9-percentage-point absolute dif-
ference) in the rates of cesarean section, but we 
cannot rule out a smaller effect. The observed 
confidence intervals suggest that the rate of 
cesarean delivery could range from a 28% lower 
rate to a 36% higher rate with induction than 
with expectant management.
The rate of assisted vaginal delivery appeared 
to be higher in the induction group than in the 
expectant-management group, although the dif-
ference was not significant. In countries with 
higher rates of cesarean sections in the second 
stage of labor, the rate of cesarean delivery with 
induction of labor might be higher than the rate 
that we report in this article.
The current trial included participants from 
38 NHS hospitals and 1 Primary Care Trust orga-
nization in the United Kingdom; these hospitals 
represent a mixture of secondary- and tertiary-
level units. The results are generalizable to coun-
tries with demographic characteristics that are 
similar to those of the United Kingdom.
The design of our trial was pragmatic; in both 
trial groups, units were encouraged to use their 
usual method of induction in women who re-
quired induction. There is considerable heteroge-
neity in the methods used for induction around 
the world. These methods of induction have differ-
ing efficacy.10 Most participating units used prosta-
glandin ripening followed, if necessary, by amni-
otomy and oxytocin infusion. It is unclear whether 
the results of this trial would be generalizable to 
centers that use other methods of induction.
Previous studies of induction of labor involv-
ing women of advanced maternal age have been 
observational and have shown an increased risk 
of cesarean delivery associated with induction.28-30 
Numerous randomized trials have assessed the 
effect of labor induction at term for other indica-
tions, and these trials have been included in 
three recent meta-analyses, all of which showed 
a lower rate of cesarean delivery among women 
assigned to induction of labor than among 
women assigned to expectant management.16,31,32 
Our results similarly did not indicate a higher 
rate of caesarean delivery among women who 
received induction than among women who re-
ceived expectant management.
Our trial did not address whether induction 
of labor at 39 weeks of gestation can prevent 
stillbirths. It does, however, provide support for 
the safety of performing a larger trial to test the 
effects of induction on stillbirth and uncommon 
adverse neonatal outcomes in women 35 years of 
age or older, although such a trial would need to 
be extremely large.
Some observational studies have suggested a 
possible association between delivery at “early-
term” gestations (37 to 39 weeks) versus “late-
term” gestations (40 to 41 weeks)11-14 and a 
subtle long-term effect on children’s develop-
ment and educational attainment. However, data 
from randomized trials to inform outcomes in 
infants after discharge from the hospital are 
lacking.
In summary, in women of advanced maternal 
age, induction of labor at 39 weeks of gestation, 
as compared with expectant management, had 
no significant effect on the rate of cesarean sec-
tion and was not associated with adverse short-
term effects on maternal or neonatal outcomes.
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